[1]Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and ageofonset distributions of DSMIV disorders in the National Comorbidity Survey Replication[J]. Arch Gen Psychiatry, 2005,62(6):593602.
[2]Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease[J].N Engl J Med, 2012,366(4):321329.
[3]Khan FM, Kulaksizoglu B, Cilingiroglu M.Depression and coronary heart disease[J].Curr Atheroscler Rep,2010,12(2):105109.
[4]Anda R, Williamson D, Jones D, et al.Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults[J].Epidemiology, 1993,4(4):285294.
[5]Holahan CJ, Pahl SA, Cronkite RC, et al.Depression and vulnerability to incident physical illness across 10 years[J].J Affect Disord, 2010,123(1/3):222229.
[6]Ford DE, Mead LA, Chang PP, et al.Depression is a risk factor for coronary artery disease in men:the precursors study[J].Arch Intern Med, 1998,158(13):14221426.
[7]Surtees PG, Wainwright NW, Luben RN, et al.Depression and ischemic heart disease mortality:evidence from the EPICNorfolk United Kingdom prospective cohort study[J].Am J Psychiatry, 2008,165(4):515523.
[8]Meijer A, Conradi HJ, Bos EH, et al.Prognostic association of depression following myocardial infarction with mortality and cardiovascular events:a metaanalysis of 25 years of research[J].Gen Hosp Psychiatry, 2011,33(3):203216.
[9]Nabi H, Kivimki M, Empana JP, et al.Combined effects of depressive symptoms and resting heart rate on mortality:the Whitehall II prospective cohort study[J].J Clin Psychiatry, 2011,72(9):11991206.
[10]Hoen PW, Whooley MA, Martens EJ, et al.Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease[J].J Am Coll Cardiol,2010,56(11):838844.
[11]Otte C, McCaffery J, Ali S, et al.Association of a serotonin transporter polymorphism (5HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease:the Heart and Soul Study[J].Am J Psychiatry, 2007,164(9):13791384.
[12]Su S, Lampert R, Lee F, et al.Common genes contribute to depressive symptoms and heart rate variability:the Twins Heart Study[J].Twin Res Hum Genet,2010,13(1):19.
[13]Bozzini S, Gambelli P, Boiocchi C, et al.Coronary artery disease and depression:possible role of brainderived neurotrophic factor and serotonin transporter gene polymorphisms[J].Int J Mol Med, 2009,24(6):813818.
[14]Cohen BE, Panguluri P, Na B, et al.Psychological risk factors and the metabolic syndrome in patients with coronary heart disease:findings from the Heart and Soul Study[J].Psychiatry Res, 2010,175(1/2):133137.
[15]Baune BT, Stuart M, Gilmour A,et al.Moderators of the relationship between depression and cardiovascular disorders:a systematic review[J].Gen Hosp Psychiatry, 2012,34(5):478492.
[16]Jokinen J, Nordstrm P.HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients[J].J Affect Disord, 2009,116(1/2):8892.
[17]Vogelzangs N, Beekman AT, Milaneschi Y, et al.Urinary cortisol and sixyear risk of allcause and cardiovascular mortality.J Clin Endocrinol Metab, 2010,95(11):49594964.
[18]Almeida OP, Alfonso H, Flicker L, et al.Thyroid hormones and depression:the Health in Men study[J].Am J Geriatr Psychiatry, 2011,19(9):763770.
[19]Howren MB, Lamkin DM, Suls J.Associations of depression with Creactive protein, IL1, and IL6:a metaanalysis[J].Psychosom Med, 2009,71(2):171186.
[20]Elovainio M, Aalto AM, Kivimki M, et al.Depression and Creactive protein:populationbased Health 2000 Study[J].Psychosom Med, 2009,71(4):423430.
[21]Pasco JA, Nicholson GC, Williams LJ, et al.Association of highsensitivity Creactive protein with de novo major depression[J].Br J Psychiatry, 2010,197(5):372377.
[22]Davidson KW, Schwartz JE, Kirkland SA, et al.Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study) [J].Am J Cardiol, 2009,103(6):755761.
[23]BlascoLafarga C, MartinezNavarro I, Sisamon ME, et al.Linear and nonlinear heart rate dynamics in elderly inpatients. Relations with comorbidity and depression[J].Medicina (Kaunas), 2010,46(6):393400.
[24]Parakh K, Sakhuja A, Bhat U, et al.Platelet function in patients with depression[J].South Med J, 2008,101(6):612617.
[25]Gehi A, Musselman D, Otte C, et al.Depression and platelet activation in outpatients with stable coronary heart disease:findings from the Heart and Soul Study[J].Psychiatry Res, 2010,175(3):200204.
[26]Atar D, Malinin A, Takserman A, et al.Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans[J].J Clin Psychopharmacol, 2006,26(2):172177.
[27]Tomfohr LM, Martin TM, Miller GE.Symptoms of depression and impaired endothelial function in healthy adolescent women[J].J Behav Med, 2008,31(2):137143.
[28]Cooper DC, Tomfohr LM, Milic MS,et al.Depressed mood and flowmediated dilation:a systematic review and metaanalysis[J].Psychosom Med, 2011,73(5):360369.
[29]Yager S, Forlenza MJ, Miller GE. Depression and oxidative damage to lipids[J].Psychoneuroendocrinology, 2010,35(9):13561362.
[30]Maes M, Mihaylova I, Kubera M, et al.Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression:markers that further explain the higher incidence of neurodegeneration and coronary artery disease[J].J Affect Disord, 2010,125(1/3):287294. |